Annual Report 2020

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2020 135 The United Laboratories International Holdings Limited Annual Report 2020 39. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Credit risk and impairment assessment (Continued) Changes in the loss allowance for other receivables are mainly due to: 31/12/2020 31/12/2019 Increase in Increase in Lifetime ECL Increase (decrease) in (not credit- (decrease) in 12m ECL impaired) 12m ECL RMB’000 RMB’000 RMB’000 One debtor with a gross carrying amount of RMB773,693,000 (2019: N/A) transferred to lifetime ECL (not-credit impaired) (8,821) 8,821 – Settlement by one debtor with a gross carrying amount of RMB300,000,000 (2019: N/A) (4,562) – – Additional ECL on one debtor with a gross carrying amount of RMB552,498,000 (2019: N/A) upon transfer to lifetime ECL (not-credit impaired) – 71,278 – Newly originated other receivable balance with gross amount of RMB101,726,000 (2019: RMB823,872,000) 5,700 – 16,417 Settlement in full of other receivables with a gross carrying amount of RMB29,739,000 (2019: RMB59,201,000) (3,034) – (6,411)